Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy G1 Therapeutics (GTHX) shares
Learn how to easily invest in G1 Therapeutics shares.
G1 Therapeutics is a biotechnology business based in the US. G1 Therapeutics stocks (GTHX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $23.98 – a decrease of 10.88% over the previous week. G1 Therapeutics employs 122 staff and has a trailing 12-month revenue of around $42.2 million.
How to buy shares in G1 Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – GTHX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in G1 Therapeutics?
- Has coronavirus impacted G1 Therapeutics shares?
- G1 Therapeutics shares summary
- Compare share dealing platforms
- Is G1 Therapeutics stock a buy or sell?
- G1 Therapeutics performance over time
- G1 Therapeutics's financials
- How volatile are G1 Therapeutics shares?
- Does G1 Therapeutics pay a dividend?
- Other common questions
G1 Therapeutics stock price (NASDAQ:GTHX)Use our graph to track the performance of GTHX stocks over time.
G1 Therapeutics shares at a glance
|Latest market close||$9.01|
|52-week range||$9.31 - $37.07|
|50-day moving average||$11.88|
|200-day moving average||$16.67|
|Wall St. target price||$41.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.28|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy G1 Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
G1 Therapeutics price performance over time
|1 week (2022-01-13)||-5.16%|
|1 month (2021-12-21)||-16.88%|
|3 months (2021-10-21)||-32.05%|
|6 months (2021-07-21)||-51.56%|
|1 year (2021-01-21)||-57.90%|
|2 years (2020-01-21)||-63.52%|
|3 years (2019-01-18)||20.13|
|5 years (2017-01-17)||N/A|
G1 Therapeutics financials
|Revenue TTM||$42.2 million|
|Gross profit TTM||$45.3 million|
|Return on assets TTM||-32.13%|
|Return on equity TTM||-71.14%|
|Market capitalisation||$429.9 million|
TTM: trailing 12 months
G1 Therapeutics share dividends
We're not expecting G1 Therapeutics to pay a dividend over the next 12 months.
G1 Therapeutics share price volatility
Over the last 12 months, G1 Therapeutics's shares have ranged in value from as little as $9.31 up to $37.069. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while G1 Therapeutics's is 2.0837. This would suggest that G1 Therapeutics's shares are significantly more volatile than the average for this exchange and represent a higher risk.
G1 Therapeutics overview
G1 Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer. It is also developing trilaciclib, an intravenous cyclin-dependent kinases (CDK) 4/6 inhibitor that is in Phase III clinical trials for patients with first line colorectal cancer, as well as Phase II clinical trials for the treatment of neoadjuvant breast cancer; lerociclib, an oral CDK4/6 inhibitor for multiple oncology indications; and rintodestrant, an oral selective estrogen receptor degrader, which is in Phase IIa clinical trials for the treatment of estrogen receptor-positive and HER2-negative breast cancer. The company has a collaboration with Quantum Leap Healthcare Collaborative to evaluate trilaciclib for neoadjuvant treatment of locally advanced breast cancer; and license agreement with EQRx, Inc. and Genor Biopharma Co. Inc.
G1 Therapeutics in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.